These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30091313)

  • 1. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
    Kim SH; Jung HH; Lee CK
    Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
    Harry RA; Anderson AE; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
    Van Brussel I; Lee WP; Rombouts M; Nuyts AH; Heylen M; De Winter BY; Cools N; Schrijvers DM
    Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies.
    Suuring M; Moreau A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
    Hilkens CM; Isaacs JD
    Clin Exp Immunol; 2013 May; 172(2):148-57. PubMed ID: 23574312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccination in autoimmune disease.
    Gross CC; Wiendl H
    Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.
    Liu C; Zhu J; Mi Y; Jin T
    J Neuroinflammation; 2022 Dec; 19(1):298. PubMed ID: 36510261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
    Stoop JN; Robinson JH; Hilkens CM
    Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
    García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
    Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
    Passeri L; Marta F; Bassi V; Gregori S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Funda DP; Palová-Jelínková L; Goliáš J; Kroulíková Z; Fajstová A; Hudcovic T; Špíšek R
    Front Immunol; 2019; 10():967. PubMed ID: 31139178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
    Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
    Front Immunol; 2019; 10():2068. PubMed ID: 31555285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
    Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
    Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus.
    Ritprajak P; Kaewraemruaen C; Hirankarn N
    Cells; 2019 Oct; 8(10):. PubMed ID: 31640263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
    Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
    PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study.
    Jauregui-Amezaga A; Cabezón R; Ramírez-Morros A; España C; Rimola J; Bru C; Pinó-Donnay S; Gallego M; Masamunt MC; Ordás I; Lozano M; Cid J; Panés J; Benítez-Ribas D; Ricart E
    J Crohns Colitis; 2015 Dec; 9(12):1071-8. PubMed ID: 26303633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
    Wei HJ; Letterio JJ; Pareek TK
    J Vis Exp; 2018 May; (135):. PubMed ID: 29863666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.
    Ma Y; Shi R; Li F; Chang H
    Cell Commun Signal; 2024 May; 22(1):262. PubMed ID: 38715122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.